Gabelli Funds LLC grew its holdings in shares of Rentokil Initial plc (NYSE:RTO - Free Report) by 18.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 76,500 shares of the company's stock after purchasing an additional 12,000 shares during the period. Gabelli Funds LLC's holdings in Rentokil Initial were worth $1,937,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cape Investment Advisory Inc. increased its holdings in shares of Rentokil Initial by 65.2% during the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock valued at $38,000 after acquiring an additional 594 shares in the last quarter. CENTRAL TRUST Co increased its stake in Rentokil Initial by 15,208.3% during the 4th quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock valued at $47,000 after purchasing an additional 1,825 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Rentokil Initial by 486.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock worth $49,000 after buying an additional 1,611 shares during the period. Cromwell Holdings LLC purchased a new stake in shares of Rentokil Initial during the fourth quarter valued at $59,000. Finally, Blue Trust Inc. increased its position in shares of Rentokil Initial by 140.4% in the 4th quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock valued at $60,000 after acquiring an additional 1,403 shares during the period. 9.91% of the stock is currently owned by hedge funds and other institutional investors.
Rentokil Initial Stock Performance
Rentokil Initial stock traded down $0.23 during midday trading on Wednesday, hitting $22.57. 2,271,286 shares of the company were exchanged, compared to its average volume of 765,269. Rentokil Initial plc has a fifty-two week low of $19.60 and a fifty-two week high of $34.07. The firm has a market capitalization of $11.40 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 7.95 and a beta of 1.07. The business has a fifty day simple moving average of $23.16 and a two-hundred day simple moving average of $24.44. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04.
Rentokil Initial Dividend Announcement
The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 4th will be paid a $0.3825 dividend. This represents a dividend yield of 2.4%. The ex-dividend date of this dividend is Friday, April 4th. Rentokil Initial's dividend payout ratio is currently 43.71%.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Rentokil Initial in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Rentokil Initial has a consensus rating of "Moderate Buy".
Read Our Latest Research Report on Rentokil Initial
Rentokil Initial Profile
(
Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Read More

Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.